Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - azithromycin (as azithromycin dihydrate) - injection, powder, for solution - 100 mg/ml - azithromycin (as azithromycin dihydrate) 100 mg/ml

Canada - English - Health Canada

sandoz canada incorporated - voriconazole - powder for solution - 200mg - voriconazole 200mg - azoles

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

laboratoires anios, france - peracetic acid - solution - 0.10 - 0.20 %

Canada - English - Health Canada

charlotte products ltd. - peracetic acid; acetic acid; hydrogen peroxide - solution - 5.9%; 7%; 27.3% - peracetic acid 5.9%; acetic acid 7%; hydrogen peroxide 27.3% - disinfectants (for agents used on object)

Canada - English - Health Canada

pfizer canada ulc - voriconazole - powder for solution - 200mg - voriconazole 200mg - azoles

Canada - English - Health Canada

pfizer canada ulc - azithromycin - powder for solution - 500mg - azithromycin 500mg - other macrolides

Canada - English - Health Canada

eli lilly canada inc - olanzapine (olanzapine tartrate) - powder for solution - 10mg - olanzapine (olanzapine tartrate) 10mg - atypical antipsychotics

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tofacitinib citrate, quantity: 1.62 mg/ml (equivalent: tofacitinib, qty 1 mg/ml) - solution - excipient ingredients: xylitol; lactic acid; sucralose; sodium benzoate; hydrochloric acid; purified water; flavour - rheumatoid arthritis (ra),xeljanz is indicated for the treatment of moderate to severe active rheumatoid arthritis in adults who have had an inadequate response or are intolerant to methotrexate. xeljanz can be used alone or in combination with conventional synthetic disease-modifying antirheumatic drugs (dmards), including methotrexate.,psoriatic arthritis (psa),xeljanz in combination with conventional synthetic dmards is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response to a prior dmard therapy.,ulcerative colitis (uc),xeljanz is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biological therapy.,ankylosing spondylitis (as),xeljanz is indicated for the treatment of adult patients with active ankylosing spondylitis who have responded inadequately to conventional therapy.,juvenile idiopathic arthritis (jia),xeljanz is indicated for the treatment of active polyarticular course juvenile idiopathic arthritis (rheumatoid factor positive [rf+] or negative [rf-] polyarthritis, extended oligoarthritis and systemic juvenile arthritis without systemic features for six months) and juvenile psoriatic arthritis in patients 2 years of age and older, who have responded inadequately to previous therapy with dmards.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sopura australia pty. ltd. - hydrogen peroxide; peracetic acid - liquid concentrate - hydrogen peroxide ungrouped active 110.0 g/l; peracetic acid acid-general active 160.0 g/l - microbiocide

Australia - English - Department of Health (Therapeutic Goods Administration)

steris australia pty ltd - 58056 - peracetic acid device disinfectant/sterilant test strip - test strip, incorporating a pad of absorbent material impregnated with chemical indicators and dyes, intended to be used to rapidly indicate, through colour change, the concentration of peracetic acid in a solution, after preparation, to ensure the presence of the manufacture's recommended minimum effective concentration (mec). this is a single use device.